MEDINET Co., Ltd. (TYO:2370)

Market Cap	8.21B
Revenue (ttm)	998.00M
Net Income (ttm)	-3.05B
Shares Out	264.73M
EPS (ttm)	-26.77
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	389,300
Average Volume	1,115,250
Open	31.00
Previous Close	31.00
Day's Range	30.00 - 31.00
52-Week Range	28.00 - 57.00
Beta	0.58
RSI	43.87
Earnings Date	May 9, 2025

About MEDINET

MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan. Its solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy. The company also manufactures regenerative medical/investigational and specified cell products. In addition, its value chain solutions comprise personnel training, facility and equipment design, facility operations and management, prep...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 92
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2370

Financial Performance

In 2018, MEDINET's revenue was 998.00 million, a decrease of -41.43% compared to the previous year's 1.70 billion. Losses were -3.05 billion, 17.1% more than in 2017.